1. Home
  2. TDTH vs SRZN Comparison

TDTH vs SRZN Comparison

Compare TDTH & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TDTH
  • SRZN
  • Stock Information
  • Founded
  • TDTH 2014
  • SRZN 2015
  • Country
  • TDTH Singapore
  • SRZN United States
  • Employees
  • TDTH N/A
  • SRZN N/A
  • Industry
  • TDTH
  • SRZN Medicinal Chemicals and Botanical Products
  • Sector
  • TDTH
  • SRZN Health Care
  • Exchange
  • TDTH NYSE
  • SRZN Nasdaq
  • Market Cap
  • TDTH 42.7M
  • SRZN 37.7M
  • IPO Year
  • TDTH 2024
  • SRZN N/A
  • Fundamental
  • Price
  • TDTH $0.35
  • SRZN $11.14
  • Analyst Decision
  • TDTH
  • SRZN Strong Buy
  • Analyst Count
  • TDTH 0
  • SRZN 2
  • Target Price
  • TDTH N/A
  • SRZN $38.50
  • AVG Volume (30 Days)
  • TDTH 2.7M
  • SRZN 12.4K
  • Earning Date
  • TDTH 05-25-2025
  • SRZN 05-07-2025
  • Dividend Yield
  • TDTH N/A
  • SRZN N/A
  • EPS Growth
  • TDTH N/A
  • SRZN N/A
  • EPS
  • TDTH N/A
  • SRZN N/A
  • Revenue
  • TDTH $1,380,783.00
  • SRZN $10,000,000.00
  • Revenue This Year
  • TDTH N/A
  • SRZN N/A
  • Revenue Next Year
  • TDTH N/A
  • SRZN N/A
  • P/E Ratio
  • TDTH N/A
  • SRZN N/A
  • Revenue Growth
  • TDTH 8.81
  • SRZN N/A
  • 52 Week Low
  • TDTH $0.40
  • SRZN $6.00
  • 52 Week High
  • TDTH $4.74
  • SRZN $18.17
  • Technical
  • Relative Strength Index (RSI)
  • TDTH N/A
  • SRZN 47.63
  • Support Level
  • TDTH N/A
  • SRZN $10.34
  • Resistance Level
  • TDTH N/A
  • SRZN $14.00
  • Average True Range (ATR)
  • TDTH 0.00
  • SRZN 0.95
  • MACD
  • TDTH 0.00
  • SRZN -0.07
  • Stochastic Oscillator
  • TDTH 0.00
  • SRZN 26.63

About TDTH TRIDENT DIGITAL TECH HOLDINGS LTD SPON ADS EACH REP 8 ORD CL B

Trident Digital Tech Holdings is principally engaged in the provision of business consulting service and IT customization solutions in the Republic of Singapore.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: